PDCD4 and pancreatic neoplasm: Similarly, overexpression of miRNA-320a in pancreatic cancer strongly contributes to the acquisition of characteristics, such as high levels of proliferation, invasion, metastasis, and drug resistance, as well as driving cells towards epithelial–mesenchymal transition by downregulating programmed cell death 4 (PDCD4) [90].